Division of Pediatric Infectious Diseases, Children's Mercy, Kansas City, Missouri.
Division of Pediatric Infectious Diseases, Children's Hospital Colorado Aurora.
J Pediatric Infect Dis Soc. 2017 Jun 1;6(2):111-115. doi: 10.1093/jpids/piw086.
A 9-valent human papillomavirus vaccine is now recommended as a 2-dose series (0, 6-12 months) for healthy adolescents 9-14 years. Meningococcal type B (MenB)-FHbp (Trumenba), previously a 3-dose series, may be given in a 2-dose series (0, 6 months) to healthy adolescents; MenB vaccination remains a Category B recommendation (individual clinical decision making) for healthy adolescents. The wording for the recommendations for the hepatitis B vaccine birth dose was strengthened to encourage administration of the birth dose by 24 hours of age.
目前推荐将 9 价人乳头瘤病毒疫苗作为 2 剂程序（0、6-12 个月）用于 9-14 岁健康青少年。脑膜炎奈瑟菌 B 型（MenB）-FHbp（特鲁姆巴），此前为 3 剂程序，可用于 2 剂程序（0、6 个月）用于健康青少年；脑膜炎 B 型疫苗接种仍然是健康青少年的 B 类推荐（个体临床决策）。乙肝疫苗基础免疫剂量的推荐措辞得到加强，鼓励在 24 小时龄内给予基础免疫剂量。
